Publications
114
Citations
406
Est. group size
~11
Recurring co-author estimate
Active years
17
Publishing since 2010
Typically publishes in teams of ~18 · 13% small-team papers (≤3 authors) · across 19 venues
- Genomic characterization of upper tract urothelial carcinoma (UTUC) with or without sarcomatoid differentiation.
Journal of Clinical Oncology · 2026
- Geographic disparities in the availability of renal cell carcinoma (RCC) clinical trials in the United States (US).
Journal of Clinical Oncology · 2026
- Prognosis of patients (pts) with synchronous vs metachronous metastatic or locally advanced urothelial carcinoma (la/mUC).
Journal of Clinical Oncology · 2026
- Real-world efficacy and safety of tivozanib in metastatic renal cell carcinoma in a diverse cohort: A multicenter study from the City of Hope enterprise.
Journal of Clinical Oncology · 2026
- Impact of age on outcomes in metastatic non–clear cell renal cell carcinoma (mnccRCC): A real-world TriNetX analysis.
Journal of Clinical Oncology · 2026
- Availability of clinical trials investigating prostate cancer (PC) in the United States (US).
Journal of Clinical Oncology · 2026
- Regional variations in bladder cancer (BC) clinical trial availability within the United States (US).
Journal of Clinical Oncology · 2026
- Efficacy of <sup>177</sup> Lu-PSMA-617 in neuroendocrine prostate cancer.
Journal of Clinical Oncology · 2026
- Abstract 3911: Use of ALK inhibitors in patients with non-lung malignancies bearing <i>ALK</i> alteration prolongs treatment duration.
Cancer Research · 2026
- Biomarker-defined outcomes in metastatic clear cell renal cell carcinoma (mccRCC) receiving first-line (1L) immune checkpoint inhibitor-based therapy.
Journal of Clinical Oncology · 2026
- Randomized phase 1 trial of cisplatin-based chemotherapy with or without sodium thiosulfate for men with metastatic germ cell tumor (GCT).
Journal of Clinical Oncology · 2026
- PSA nadir–stratified outcomes of ARPI doublet and docetaxel triplet therapy in metastatic prostate cancer.
Journal of Clinical Oncology · 2026
- Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors
Cancer Research Communications · 2026
- Emerging antibody-drug conjugates in metastatic castration-resistant prostate cancer
Urologic Oncology Seminars and Original Investigations · 2026
- Figure 1 from Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors
2026
- Journal of Clinical Oncology×32
- Clinical Genitourinary Cancer×6
- Annals of Oncology×5
- European Urology×4
- Cancer Research×4
- Yuanquan Yang
Medicine · The Ohio State University
- Sarah Yentz
Medicine · University of Michigan
- Lingbin Meng
Medicine · The Ohio State University
- Junshui Ma
Medicine · The Ohio State University
- Lynne Brophy
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile